跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Soniphen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Soniphen
Approved
STANDARD
Soniphen
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a502f315a8bb4121
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
a502f315a8bb4121
Drug Approval Philippines Name
Soniphen
Product Name
Soniphen
Registration Number
DR-XY38500
Brand Name
Soniphen
Generic Name
Diphenhydramine Hydrochloride
Dosage Form
Capsule
Dosage Strength
50mg
Manufacturer
Amherst Laboratories, Inc.
Trader
United Laboratories, Inc. (UNILAB, Inc.)
Issuance Date
30 January 2022
Expiry Date
09 January 2027
Pharmacologic Category
Antihistamine/ Anticholinergic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a502f315a8bb4121
Type
Standard
Back to Philippines FDA Approvals